Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)

RecruitingObservational study

Improving Survival for Those With Metastatic Lobular Breast Cancer Through Development of the Multi-center PLUMB Registry-a Prospective Study of LobUlar Metastatic Breast Cancer

Who can join

Ages 18 and older · All sexes

Full eligibility criteria

Inclusion Criteria:

1. Histologically confirmed invasive lobular carcinoma. Mixed lobular/ductal cancer is allowed.
2. Age \>=18 years
3. Any receptor subtype.
4. Ability to understand a written informed consent document, and the willingness to sign it.

Exclusion Criteria:

1. Stage I-III breast cancer.
2. Lack of lobular histology on tumor biopsy.
3. Other active cancer (prior treated cancer with no current evidence of disease is allowed).

About the study

This is a prospective observational registry for patients with invasive lobular carcinoma (ILC) of the breast. After the first 1cohort is enrolled, the collected data will be utilized to develop an ILC specific response assessment tool.

What is being tested

Blood Specimen (procedure)

Sponsor: University of California, San Francisco · Participants: 150 · Started: Dec 20, 2023

Contact the study team

Venezia Garza · Phone: 415-353-8732

Official record on ClinicalTrials.gov — NCT05964504

Locations in the U.S.

California	University of California, San Diego, San Diego University of California, San Francisco, San Francisco
Pennsylvania	Abramson Cancer Center, Philadelphia
Texas	MD Anderson Cancer Center, Houston

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.